InsiderClue
Insiders · Profile

Eisner Mark

EVP and Chief Medical Officer at Vir Biotechnology · EVP, Chief Medical Officer at KYNTRA BIO. Filing since 2 Mar 2023. CIK 0001834161

VIR Vir Biotechnology, Inc. EVP and Chief Medical Officer · 5 trades KYNB KYNTRA BIO, INC. EVP, Chief Medical Officer · 6 trades
Company
Date
Role
Action
Shares
Amount
Of holding
VIR Vir Biotechnology, Inc.
25 Feb 2026
EVP and Chief Medical Officer
Sold on a plan
1,889
$18.55K
1.2%
VIR Vir Biotechnology, Inc.
24 Feb 2026
EVP and Chief Medical Officer
Sold on a plan
1,616
$15.40K
1.0%
VIR Vir Biotechnology, Inc.
23 Feb 2026
EVP and Chief Medical Officer
Sold on a plan
2,089
$15.57K
1.3%
VIR Vir Biotechnology, Inc.
17 Jul 2025
EVP and Chief Medical Officer
Sold on a plan
3,586
$19.63K
3.3%
VIR Vir Biotechnology, Inc.
15 Jul 2025
EVP and Chief Medical Officer
Sold on a plan
6,796
$37.16K
5.9%
KYNB KYNTRA BIO, INC.
7 Jun 2023
EVP, Chief Medical Officer
Sold at will
2,042
$34.79K
1.2%
KYNB KYNTRA BIO, INC.
2 Jun 2023
EVP, Chief Medical Officer
Sold at will
1,090
$20.52K
0.7%
KYNB KYNTRA BIO, INC.
4 Apr 2023
Chief Medical Officer
Sold at will
9,182
$172.47K
5.2%
KYNB KYNTRA BIO, INC.
10 Mar 2023
Chief Medical Officer
Sold, plan not stated
10,140
$204.80K
5.5%
KYNB KYNTRA BIO, INC.
8 Mar 2023
Chief Medical Officer
Sold, plan not stated
7,363
$155.77K
4.3%
KYNB KYNTRA BIO, INC.
2 Mar 2023
Chief Medical Officer
Sold, plan not stated
1,187
$25.96K
0.7%
11 decisions on file.